Table 3.
Association of nuclear and mitochondrial ancestry with breast cancer risk in Uruguayan women
Nuclear ancestry | OR a | 95% CI | p-value |
---|---|---|---|
European | 1.05 | (0.85,1.30) | 0.63 |
African | 1.09 | (0.89,1.33) | 0.42 |
Native American | 0.84 | (0.68,1.04) | 0.10 |
N | 312 | ||
Mitochondrial ancestry | OR b | 95% CI | p-value |
European | Reference | 0.25c | |
African | 0.54 | (0.22,1.33) | 0.18 |
Native American | 0.71 | (0.42,1.20) | 0.20 |
N | 312 | ||
No H haplogroup | Reference | ||
H haplogroup | 1.99 | (1.13,3.51) | 0.02 |
N | 312 | ||
No H haplogroup | Reference | ||
H haplogroup | 1.84 | (0.97,3.51) | 0.06 |
Nd | 171 |
All regression models were adjusted for age, education and hospital. Mitochondrial ancestry regression models were additionally adjusted for European nuclear ancestry.
aBreast cancer OR per 25% increase in ancestry.
bBreast cancer OR for women carrying an African or Native American mitochondrial haplogroup compared to women carrying a European haplogroup, or women carrying a H haplogroup compared to those carrying a different haplogroup.
cP-value for the model.
dAnalysis restricted to women carrying a European mitochondrial haplogroup.